Rubitecan
In Stock•Starting at $139 for 50 mg•Purity ≥ 98%
| CAS No. | 91421-42-0 |
|---|---|
| MDL No. | MFCD06656294 |
| MF | C20H15N3O6 |
| MW | 393.30 |
| InChI Key | VHXNKPBCCMUMSW-FQEVSTJZSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 50 mg | 98% | $139 | In Stock | |
| 100 mg | 98% | $165 | In Stock | |
| 250 mg | 98% | $410 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Rubitecan is a pyranoindolizinoquinoline derivative of camptothecin, with a nitro group replacing the hydrogen at position 9. It functions as a prodrug for 9-aminocamptothecin. It acts as an antineoplastic agent, an EC 5.99.1.2 DNA topoisomerase inhibitor, and is classified as a C-nitro compound, a semisynthetic derivative, a tertiary alcohol, and a delta-lactone.
| CAS No. | 91421-42-0 |
|---|---|
| Product Name | Rubitecan |
Biological Targets
TOP1
Associated Conditions
urinary bladder cancer·endometrial cancer·urethra cancer·cutaneous melanoma·colorectal cancer·
* The information provided here is compiled from public sources and is for reference only.
